GlassScriptPhysician profile
Sally M Ericksen
NPI 1528375284
$1,455.40
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,011 · 2022: $444.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $238.72 | 2021-2022 | |
| Lilly USA, LLC | $185.73 | 2021-2022 | |
| Medtronic, INC. | $139.67 | 2021 | |
| Sanofi-Aventis U.S. LLC | $120.39 | 2021-2022 | |
| Antares Pharma, INC. | $102.09 | 2021-2022 | |
| Amgen INC. | $83.30 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $78.46 | 2021-2022 | |
| Corcept Therapeutics | $70.89 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $70.44 | 2021 | |
| Abbvie INC. | $67.16 | 2021 | |
| Novo Nordisk INC | $45.66 | 2021 | |
| Dexcom, INC. | $42.23 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.19 | 2021-2022 | |
| Zealand Pharma US, INC. | $30.37 | 2022 | |
| Amryt Pharma Holdings LTD | $30.25 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.65 | 2021 | |
| Abbott Laboratories | $21.40 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $18.69 | 2022 | |
| Amarin Pharma, INC. | $15.67 | 2021 | |
| Recordati_rare_diseases_inc. | $13.63 | 2021 | |
| Ascensia Diabetes Care US INC. | $13.47 | 2021 | |
| Radius Health, INC. | $12.34 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Ericksen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.